These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 23685934

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough?
    Haggiagi A, Lassman AB.
    Neuro Oncol; 2020 Aug 17; 22(8):1058-1059. PubMed ID: 32479605
    [No Abstract] [Full Text] [Related]

  • 26. Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma.
    Hsieh SY, Chan DT, Kam MK, Loong HH, Tsang WK, Poon DM, Ng SC, Poon WS.
    Hong Kong Med J; 2017 Dec 17; 23(6):594-8. PubMed ID: 28798282
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The fallacy of single-agent chemotherapy for cancer.
    Friedman HS, Maxwell J.
    J Clin Oncol; 2007 Aug 10; 25(23):3550; author reply 3550-1. PubMed ID: 17687162
    [No Abstract] [Full Text] [Related]

  • 29. The role of temozolomide in newly-diagnosed glioblastoma multiforme.
    Jenkinson MD.
    Br J Neurosurg; 2008 Jun 10; 22(3):456. PubMed ID: 18568743
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN, Lin YC, Liu MY, Chang PY.
    J Clin Neurosci; 2014 Apr 10; 21(4):701-4. PubMed ID: 24291476
    [Abstract] [Full Text] [Related]

  • 32. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo JS, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy ML, Honnorat J, Delattre JY.
    J Clin Oncol; 2011 Aug 01; 29(22):3050-5. PubMed ID: 21709196
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R.
    No To Shinkei; 2006 Dec 01; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract] [Full Text] [Related]

  • 38. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.
    Essock-Burns E, Lupo JM, Cha S, Polley MY, Butowski NA, Chang SM, Nelson SJ.
    Neuro Oncol; 2011 Jan 01; 13(1):119-31. PubMed ID: 21036812
    [Abstract] [Full Text] [Related]

  • 39. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
    Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, Xu W, Kalish V, Zupi G, Zhang J, Graziani G.
    Clin Cancer Res; 2003 Nov 01; 9(14):5370-9. PubMed ID: 14614022
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.